Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

Sanofi sheds jobs in R&D restructuring

Sanofi sheds jobs in R&D restructuring

The company has also just announced a change of CEO - Novartis pharma chief Paul Hudson will take over from Olivier Brandicourt from 1 September.

Biotech profile: Tom Evans, CEO, Vaccitech.

In 2005, he joined the Novartis Institutes for Biomedical Research as Global Head of Infectious Diseases Translational Medicine and Research. ... In September 2008 he moved to Shanghai as VP for Translational Sciences in Asia for Novartis.

Pfizer’s Talzenna cleared for breast cancer in Europe

Pfizer’s Talzenna cleared for breast cancer in Europe Alecensa (alectinib), Novartis’ Zykadia (ceritinib), and Takeda’s Alunbrig (brigatinib).

Mistrust of pharma still blocking NHS collaborations

Mistrust of pharma still blocking NHS collaborations treatments from Novartis and Bayer.

Syncona start-up Quell Therapeutics appoints chief exec

Syncona start-up Quell Therapeutics appoints chief exec Prior to that, he had served in various senior roles in positions in transplantation and immunology for Wyeth, Novartis and Roche.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics